Promises and Dangers of Stem Cell Therapies | Daniel Kota | TEDxBrookings

TEDx Talks
28 Nov 201712:38

Summary

TLDRThe speaker, a Brazilian scientist, discusses the complexities and potential dangers of stem cell treatments. He explains the spectrum of stem cells, from embryonic to adult, highlighting the risks of embryonic stem cells turning into cancer. He emphasizes the benefits of mesenchymal stem cells (MSCs) that can heal without differentiating. Despite the FDA's strict regulations, unapproved stem cell treatments are proliferating, leading to cases of harm. The speaker calls for scientists to communicate more effectively about stem cells to prevent such disasters.

Takeaways

  • 🌐 Stem cells are becoming more prevalent in clinics, but not all treatments are necessarily safe or effective.
  • 🧬 Stem cells exist across a spectrum, from embryonic to adult stem cells, each with different capabilities and risks.
  • 🚀 The differentiation potential of stem cells is high, but it also poses the greatest risk, such as turning into cancer.
  • 🔬 Scientists are working to understand the conditions that guide stem cells to become useful without causing harm.
  • 🧪 Adult stem cells, particularly mesenchymal stem cells (MSCs), can treat diseases without differentiating, using various molecular mechanisms.
  • 🏥 The FDA has not approved many stem cell treatments, indicating that the field is still largely experimental.
  • 📈 There's a surge of clinics offering unregulated stem cell treatments, which can lead to serious complications.
  • 👩‍⚕️ Some stem cell treatments are being offered without proper clinical trials, posing significant risks to patients.
  • 📊 Public understanding of stem cells is often influenced more by media and less by actual scientific sources.
  • 🌟 Scientists have a responsibility to communicate the realities of stem cell research to the public to prevent misuse and harm.

Q & A

  • What is the current situation with stem cell treatments according to the speaker?

    -The speaker indicates that there is a critical point in the history of stem cells where a massive number of treatments are available, but their regulation is becoming overwhelming, with some treatments falling through the cracks.

  • What does the speaker think about the public's understanding of science, especially on social media?

    -The speaker believes that people tend to use science as a winning argument on social media without truly understanding it, and that the public's interest in science is often superficial.

  • What is the range of stem cells according to the spectrum mentioned by the speaker?

    -The range of stem cells includes embryonic stem cells, postnatal adult stem cells, and induced pluripotent stem cells (iPS cells).

  • Why does the speaker say that embryonic stem cells carry the greatest risk?

    -Embryonic stem cells have the greatest differentiation potential, which also means they have the highest risk of going astray and turning into cancer.

  • What is the role of mesenchymal stem cells (MSCs) in disease treatment as described by the speaker?

    -Mesenchymal stem cells can treat and improve many disease models without needing to differentiate into anything. They do this by employing various molecular mechanisms such as genetic transfer, mitochondrial transfer, and secretion of anti-inflammatory proteins and growth factors.

  • How do adult stem cells differ from embryonic stem cells in terms of differentiation capacity?

    -Adult stem cells have a limited differentiation capacity as they have already decided to become a certain type of cell or are on the path to becoming one.

  • What is the significance of the discovery that stem cells can be found in fat tissue?

    -The discovery that stem cells can be found in fat tissue opens up the possibility of combining liposuction procedures with stem cell treatments, creating a perfect environment for the resurgence of unregulated stem cell treatments.

  • Why does the speaker believe that the FDA has not approved many stem cell treatments?

    -The FDA has not approved many stem cell treatments because they are very strict about safety, and stem cells are not like drugs that can be manufactured identically; they vary and are difficult to control.

  • What are two horror stories shared by the speaker about unregulated stem cell treatments?

    -One story involves a woman who received a stem cell facelift and ended up with bone growing in her face around her eyes, requiring surgical removal. The second story is about three patients with macular degeneration who had stem cells injected into their eyes, leading to disastrous outcomes.

  • What does the speaker suggest as the most reliable source of information about stem cells?

    -The speaker suggests that scientists are the most reliable source of information about stem cells, but it's scary because people often learn about scientific discoveries through non-scientific sources like comic books and sitcoms.

  • What is the speaker's view on how scientists should approach public communication about stem cells?

    -The speaker believes that scientists should take themselves less seriously, get out of their heads, and reach out to inform people about stem cells to prevent disasters and ensure that good treatments make it to the public.

Outlines

00:00

🧬 Stem Cells: The Current State and Challenges

The speaker begins by addressing the audience as a scientist and humorously discusses the public's curiosity about stem cells. They note the difficulty in answering questions about stem cell research succinctly. The speaker then shares their personal journey from Brazil to the United States, where they have been involved in stem cell research for the past decade. They highlight the current state of stem cell treatments, emphasizing the sheer number of treatments available and the regulatory challenges faced by agencies like the FDA. The speaker explains the spectrum of stem cells, from embryonic to adult stem cells, and introduces induced pluripotent stem cells (iPS cells). They discuss the potential and risks associated with embryonic stem cells and iPS cells, like the possibility of turning into cancer if not properly controlled.

05:02

💉 Mesenchymal Stem Cells: The Multi-Tasking Heroes

The speaker delves into the discovery of mesenchymal stem cells (MSCs), which have shown promising results in treating various diseases without needing to differentiate into other cell types. They explain how these adult stem cells employ a variety of molecular mechanisms, such as genetic transfer and secretion of proteins, to modulate the body's systems towards healing. The speaker humorously compares these cells to responsible adults, contrasting them with hypothetical 'teenage stem cells' that would be less effective. They also discuss the prevalence of MSCs in various organs, including adipose tissue, and the potential for combining liposuction with stem cell treatments. The speaker raises concerns about the lack of FDA-approved stem cell treatments, except for specific bone restoration and cancer cases, and the rise of unregulated clinics offering unapproved treatments.

10:04

👁️‍🗨️ The Dangers of Unregulated Stem Cell Treatments

The speaker shares two cautionary tales of unregulated stem cell treatments gone wrong. The first involves a woman who received stem cell injections for a facelift, which resulted in the formation of bone in her face, requiring surgical removal. The second story is about three elderly patients with macular degeneration who were injected with stem cells directly into their eyes, leading to disastrous outcomes. The speaker criticizes the physician in the second case for falsely advertising the procedure as legitimate by starting an FDA clinical trial. The speaker emphasizes the importance of scientists being the most reliable source of information on stem cells and the need for better public education to prevent such tragedies. They also touch on the irony that people often learn about scientific discoveries through non-scientific sources like comic books and sitcoms, suggesting that scientists need to do a better job of communicating their findings to the public.

Mindmap

Keywords

💡Stem Cells

Stem cells are undifferentiated cells that have the unique ability to develop into specialized cells. They are a central theme in the video, as they hold great potential for treating various diseases and conditions. The speaker discusses different types of stem cells, such as embryonic stem cells and induced pluripotent stem cells (iPS cells), and their potential applications and risks.

💡Differentiation Potential

Differentiation potential refers to the ability of stem cells to develop into different types of cells. The video emphasizes that embryonic stem cells have the greatest differentiation potential, which is both a strength and a risk, as it can lead to the development of cancer if not properly controlled.

💡Mesenchymal Stem Cells (MSCs)

Mesenchymal Stem Cells, or MSCs, are a subset of adult stem cells that have shown promising results in treating diseases without needing to differentiate into other cell types. They achieve this by employing various molecular mechanisms to modulate the body's systems towards healing, as mentioned in the script when discussing their role in the stem cell revolution.

💡Induced Pluripotent Stem Cells (iPS Cells)

iPS cells are adult cells that have been genetically reprogrammed to behave like embryonic stem cells. They represent a significant advancement in stem cell research, as they can potentially be used to generate any type of cell needed for therapy without the ethical concerns associated with embryonic stem cells.

💡Regulatory Agencies

Regulatory agencies like the FDA in the US are responsible for ensuring the safety and efficacy of medical treatments, including stem cell therapies. The video discusses the challenges these agencies face in regulating the overwhelming number of stem cell treatments and the potential for unsafe treatments to slip through the cracks.

💡Stem Cell Treatments

Stem cell treatments involve the use of stem cells to repair or replace damaged cells or tissues. The video highlights the promise of these treatments but also the need for caution, as not all treatments have been approved by regulatory agencies and some can lead to serious complications.

💡Paradigm Shift

A paradigm shift refers to a fundamental change in approach or underlying assumptions. In the context of the video, the discovery that MSCs can treat diseases without differentiating represents a paradigm shift in stem cell research, changing the way scientists think about the potential uses of stem cells.

💡Adipose Tissue

Adipose tissue, or fat tissue, is mentioned as a source of stem cells. The video suggests that stem cell treatments could be combined with liposuction procedures to provide a readily available source of stem cells for therapy, highlighting the potential for innovative approaches to treatment.

💡Snake Oil

Snake oil, in the context of the video, refers to unproven or fraudulent medical treatments. The speaker warns about the rise of stem cell treatments being offered without proper scientific backing, likening them to snake oil and emphasizing the need for skepticism and regulation.

💡Scientific Literacy

Scientific literacy is the ability to understand and use scientific knowledge. The video argues for the importance of scientists communicating their findings to the public to prevent misunderstandings and misuse of stem cell technology, highlighting the role of scientific literacy in public health.

💡Clinical Trials

Clinical trials are research studies that involve human participants and are designed to evaluate the safety and efficacy of medical interventions. The video discusses the importance of clinical trials in assessing stem cell treatments and the need for caution when treatments have not undergone this rigorous testing process.

Highlights

Stem cells are coming to clinics but may not always be beneficial.

The public's interest in science often comes from social media discussions.

Stem cells exist within a large spectrum, from embryonic to adult stem cells.

Embryonic stem cells have the greatest differentiation potential but also the highest risk.

Adult stem cells, specifically mesenchymal stem cells (MSCs), can treat diseases without differentiating.

MSCs use molecular mechanisms like genetic transfer and secretion of proteins to promote healing.

Stem cells can be found in virtually every organ, including adipose tissue.

The FDA has not approved any stem cell treatments except for bone restoration and some cancer cases.

Stem cells are not like drugs; they can behave differently even when sourced from the same individual.

There is a resurgence of unregulated stem cell clinics offering unapproved treatments.

A woman developed bone in her face after receiving an unapproved stem cell facelift.

Patients with macular degeneration were blinded after receiving an unapproved stem cell injection into their eyes.

The public often learns about scientific discoveries through non-scientific sources like comic books and sitcoms.

Scientists need to communicate more effectively with the public about stem cell research.

Stem cells are coming, but it's crucial to ensure that safe and effective treatments are what reach the clinics.

Transcripts

play00:08

I'm here to tell you that stem cells are

play00:11

probably coming to a clinic near you but

play00:14

that's not necessarily a good thing you

play00:17

see whenever people find out I'm a

play00:18

scientist do you usually ask me how's

play00:21

this whole stem cell thing going and

play00:23

I'll be honest with you I for the

play00:25

longest time I had no idea how to answer

play00:27

that question you see I'm from Brazil as

play00:30

you can tell and and we and you and your

play00:34

birds in Brazil when you tell people

play00:35

you're scientists there's there's no

play00:37

follow-up question there's only this

play00:39

look on people's faces you know it's a

play00:41

mixture of sorrow concerned a little bit

play00:45

of disappointment you know it is really

play00:48

the look of a father whose daughter just

play00:50

brought a boyfriend home and it's going

play00:51

of all the choices out there I mean

play00:54

that's what you decided to go with and

play00:56

and yes and so I stuck with science and

play01:00

I was really fortunate to have the

play01:01

opportunity to come to this great

play01:03

country and for the past 10 years I have

play01:05

immersed myself in stem-cell research

play01:08

now that the but in here people are

play01:15

really interested in science right but

play01:17

like everything else nowadays the only

play01:20

time people are really interested in

play01:21

science is in social media discussions

play01:24

isn't it in social media discussions

play01:27

science seems to be such a winning

play01:28

argument I mean if you drop a scientific

play01:31

fact then you basically win the

play01:33

discussion right which is basically why

play01:35

we have discussions anyways I guess but

play01:38

as a scientist that has always baffled

play01:41

me okay because if there's one thing I

play01:42

learned in science is that David premium

play01:45

was right when he said the more we know

play01:47

the less we know and the less we know

play01:49

the more we think we know so quite

play01:52

honestly what people want to know is

play01:54

when can I go to the doctor get some of

play01:57

it simply and it's fair and I think

play02:00

there's only one way to describe the

play02:03

current situation we find ourselves in

play02:05

as it relates to stem cells and that is

play02:08

to say we have reached a critical point

play02:10

in the history of stem cells

play02:13

a point that can only be described as

play02:15

this what you see is a massive number of

play02:19

different stem-cell treatments out there

play02:21

and really the only thing between them

play02:23

and us our regulatory agencies such as

play02:26

the FDA in the US but the number of stem

play02:30

cell treatments out there are getting so

play02:31

overwhelming the some are just falling

play02:33

through the cracks and the question then

play02:37

is how did we get here and what does

play02:39

that mean to you so the first thing we

play02:44

have to understand is that stem cells

play02:46

really exists within a relatively large

play02:49

spectrum okay it starts with your

play02:51

embryonic stem cells goes through your

play02:53

postnatal adult stem cells all the way

play02:56

to adult cells that we can now it

play02:57

genetically reprogrammed to become

play02:59

embryonic like stem cells we call those

play03:02

induced pluripotent stem cells or iPS

play03:04

cells now we knew from the beginning

play03:07

that embryonic stem cells offer perhaps

play03:10

the greatest differentiation potential

play03:12

which is by the way what defines a stem

play03:14

cell is a cell that can replicate and

play03:16

giving the right cue it can

play03:18

differentiate you to something else

play03:19

hopefully something useful but we've

play03:23

always known that great differentiation

play03:26

potential also means the greatest risk

play03:28

and it's a very simple concept to grasp

play03:32

right we tell our kids I tell my kids

play03:34

they can be anything they want when they

play03:36

grow up

play03:36

all right don't you accept the chances

play03:39

of my son become a professional

play03:41

basketball player probably really slim

play03:42

right but I don't tell them them but we

play03:45

also know that there are very specific

play03:48

conditions environmental factors the

play03:51

half should be present just for a kid to

play03:53

become a functional contributing member

play03:56

of our society and more often that we

play03:58

like to admit those conditions are not

play04:00

met they're not in place and a lot of

play04:03

the kids end up going straight

play04:04

unfortunately when it comes to embryonic

play04:06

stem cells in IPS cells going astray

play04:09

really means turning into cancer and

play04:11

that's the last thing we wanted now as I

play04:14

speak and I say in an upset a lot of

play04:16

scientists by oversimplifying something

play04:18

very complex there are many scientists

play04:21

working precisely on deciphering those

play04:22

conditions and in the future it's quite

play04:24

possible that the choice between using

play04:27

neck stem cell in IPS cell we would come

play04:29

down to a moral choice but with that

play04:32

link said I have to tell you that both

play04:35

embryonic stem cells and iPS cells

play04:37

represent a very small fraction of all

play04:39

the stem cells out there what makes the

play04:42

bulk of them are really adult stem cells

play04:44

in going in we knew that adult stem

play04:47

cells have limited differentiation

play04:49

capacity after all they already decided

play04:53

to be something or on the road to become

play04:55

something but then ten years ago

play04:57

something happened that can only be

play04:59

described as a paradigm shift these

play05:02

cells are better a subset of these cells

play05:04

we call the mesenchymal stem cells or

play05:07

MSC's for short we're able to treat and

play05:11

improve a lot of experimental models of

play05:13

disease from heart attack type 1

play05:15

diabetes neurological diseases without

play05:17

ever needing to differentiate into

play05:20

anything and after 10 years of research

play05:23

I can tell you that the way they

play05:26

accomplish such features is by simply

play05:28

going at it it's by simply doing

play05:31

everything itself can possibly do in

play05:35

fact that's why we still call them adult

play05:37

stem cells because you do find them at

play05:39

various ages but can you imagine if they

play05:42

were teenager stem cells I mean first of

play05:46

all they wouldn't like to go there

play05:47

because it would be boring right and

play05:49

they were gay and they would get there

play05:51

and they wouldn't do anything it just

play05:52

being titled that the whole disease

play05:54

would just treat itself because they

play05:55

were there I mean nothing will get it

play05:57

right but as responsible adults

play06:00

themselves they go to work and they

play06:03

employ a plethora of different molecular

play06:05

mechanisms things like genetic transfer

play06:08

transfer of mitochondria secretion of

play06:11

anti inflammatory proteins secretion of

play06:13

growth factors that combine we modulate

play06:16

key systems in our body

play06:18

so I'm talking about your vascular

play06:19

system your immune system and even other

play06:21

stem cells are have in your body and

play06:23

they modulate them towards healing as

play06:26

simple as that

play06:27

and I challenge you to think about any

play06:30

disease or condition and I can guarantee

play06:33

you you would benefit from either one if

play06:36

not all of these interactions and that's

play06:39

what's causing the stem cell revolution

play06:42

we see today but that's not all

play06:45

something else happened it turns out we

play06:48

discovered we can find these cells

play06:50

virtually in every organ in your body

play06:52

including your adipose tissue your fat

play06:55

tissue so what I'm telling you is that

play06:58

you could have a stem-cell treatment at

play07:00

the same time you have liposculpture the

play07:03

future in a country like the US where

play07:06

the number of lipo sculptures or lipo

play07:09

aspirated procedures reaches almost

play07:12

300,000 cases a year you combine it with

play07:15

a relatively simple method to isolate

play07:18

those stem cells then you create a

play07:20

perfect environment for the resurgence

play07:22

of dr. Stanley and I'm not saying dr.

play07:25

Stanley had in bad intentions on this

play07:26

heart in fact I think we should have

play07:29

fallen this whole snake oil thing but

play07:31

the fact is that in the u.s.

play07:33

particularly the FDA has not yet

play07:37

approved a single stem cell treatment

play07:40

apart from stem cell for bone

play07:43

restoration in some cancer cases all the

play07:45

other stem cell treatments are not yet

play07:48

approved by the FDA and their taste is

play07:52

really strict actually it's the

play07:54

strictest regulatory agency in the world

play07:57

but I do tend to lean towards safety as

play08:01

well because that's what we live really

play08:03

talking about and there are hundreds of

play08:07

clinical trials which are really dead

play08:09

their trials studies assessing safety

play08:13

and advocacy in a very limited number of

play08:16

patients and I think it's it's quite

play08:19

simple to understand why someone would

play08:22

be concerned about those cells cells are

play08:24

not drugs

play08:25

I could manufacture drug here send out

play08:28

to Brazil and they would manufacture the

play08:31

exact same drug but I cannot guarantee

play08:33

that my stem cell in your stem cells

play08:36

will act and behave the same everything

play08:38

else should be a little bit different

play08:40

and what's worse if I can get your stem

play08:42

cells I start growing them and I give

play08:45

something to my colleague down the hall

play08:46

a few weeks later and when we come back

play08:49

and compare them they they might be

play08:51

different and the last thing is

play08:53

we know they do a lot of things but we

play08:56

don't know quite how to control them

play08:58

okay and what's really rare

play09:01

dr. stainless are popping up everywhere

play09:03

in the country and with them come the

play09:06

horror stories and I'll share two of

play09:08

them with you today first one is a

play09:10

middle-aged woman woman who saw an

play09:13

advertisement for facelift in stem cells

play09:15

facelift in stem cells now I know a few

play09:18

scientists who work with stem cells none

play09:20

of which work with facelift but this

play09:24

physician in particular decided was a

play09:26

good idea to inject stem cells in this

play09:29

patients face around her eyes and a few

play09:32

weeks later she woke up and every time

play09:34

she blinked she heard a click and you

play09:38

could think that's cool for a second to

play09:39

start freaking out and it turns out that

play09:41

stem cells in her face decided to turn

play09:44

into bone so she needed to have them

play09:46

surgically removed and granted this

play09:49

happened 10 I'm more than 10 years ago

play09:51

the second story is really recent it

play09:53

happened this year there were three

play09:56

older patients who suffer from

play09:58

degenerative disease of the eye macular

play10:01

degeneration and they also saw the

play10:03

advertisement for stem cells and the

play10:05

physician in that case decided well

play10:07

let's go step further and inject these

play10:09

cells inside our eyes directly into

play10:12

their eyes and few weeks later or in

play10:15

life and what's worse about this case is

play10:17

that the physician he had the trouble to

play10:21

go to the FDA and start a clinical trial

play10:25

so he could falsely advertise that his

play10:27

procedures were somehow legit and so we

play10:33

have really come to a point in history

play10:35

in which the most reliable source of

play10:38

information when it comes to stem cells

play10:41

are really scientists and that's very

play10:44

scary Otto ADA there was a survey done

play10:47

in Florida and they in which they asked

play10:51

people how do you first hear about

play10:53

scientific discoveries and out of 13

play10:56

different possibilities scientists

play10:58

ranked number 9 which means more people

play11:00

learn about science scientific

play11:02

discoveries by the way done by

play11:03

scientists through comic books sitcoms

play11:07

and

play11:08

that's how people hear about the

play11:09

scientific discoveries and I think

play11:11

that's largely fog of scientists

play11:14

ourselves we are largely faultless

play11:17

you know being from Brazil I think the

play11:22

biggest difference between Americas in

play11:24

Brazilians are Americans tend to think

play11:26

they tend to take themselves a little

play11:29

bit too seriously and I think it's

play11:32

because you guys don't have enough

play11:33

problems you don't right in Brazil

play11:38

there's so many issues so many problems

play11:41

because we and we we can't afford to

play11:44

make ourselves another one we wouldn't

play11:46

get out of bed but here people tend to

play11:50

think ourselves a little just I'm not

play11:52

saying we shouldn't take what you do

play11:54

seriously because I think we do and we

play11:56

must well we shouldn't take ourselves

play11:58

too seriously and scientists fall from

play12:01

the same disgrace and what we really

play12:05

need I think is science and as

play12:07

scientists we need to get out of our

play12:09

heads a little bit and reach out and

play12:11

inform people about stem cells because

play12:14

quite frankly a simple message could

play12:17

have prevented those disasters and a

play12:20

simple message will most likely prevent

play12:22

future ones because stem cells are

play12:26

coming we just have to make sure the

play12:28

good ones make it thank

play12:36

you

Rate This

5.0 / 5 (0 votes)

Etiquetas Relacionadas
Stem CellsMedical EthicsScientific ResearchRegulatory AgenciesHealthcare InnovationCancer RiskMesenchymal Stem CellsiPS CellsFDA ApprovalStem Cell TreatmentsScientific Misinformation
¿Necesitas un resumen en inglés?